Stay updated on Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Results have been posted (2025-12-22) and the study plan was updated to include cross-over (Arm Bx) and a revised enrollment target of 76 participants. The endpoints and translational components are described in greater detail, including DCR, PFS, ORR, irRECIST-based assessments, and tumor biomarker analyses.
    Difference
    3%
    Check dated 2025-12-29T08:35:38.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A consolidated Locations section was added with state sites (California, District of Columbia, Illinois, Indiana, Massachusetts, Pennsylvania, Tennessee) and prior state blocks were removed; a new Revision: v3.3.3 tag was introduced.
    Difference
    0.8%
    Check dated 2025-12-22T01:56:38.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-12-07T19:40:58.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated to v3.3.2; the previous revision v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T10:25:44.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-23T07:52:12.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The government funding notice about potential delays and the NIH Clinical Center operating status text has been removed.
    Difference
    0.3%
    Check dated 2025-11-16T05:53:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Carboplatin vs Carboplatin in Breast Cancer Clinical Trial page.